ClinConnect ClinConnect Logo
Search / Trial NCT06502457

Pain Management With Virtual Reality Hypnosis

Launched by CENTRE HOSPITALIER UNIVERSITAIRE, AMIENS · Jul 9, 2024

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Hypnosis Labor Pain Virtual Reality Labor Induction Latent Period

ClinConnect Summary

This clinical trial is exploring the use of virtual reality hypnosis as a way to manage pain during the early stages of labor. The study aims to provide an alternative to traditional pain relief methods, which can sometimes have side effects for both mothers and babies. By using virtual reality hypnosis, the researchers hope to help women feel less pain during labor and reduce the need for medication like morphine, which can affect the fetus.

To participate in this trial, women must be over 18 years old, able to speak and understand French, and currently in the early phase of labor. They should also be hospitalized and have a low-risk pregnancy. Participants can expect to engage in virtual reality hypnosis sessions designed to help manage their pain. This study is important because it seeks to offer a more natural and supportive approach to childbirth, responding to the increasing demand for non-drug pain management options.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Parturient over 18
  • Parturient who speaks and understands French
  • Parturient hospitalised prior to labour
  • Membranes intact or ruptured
  • Spontaneous or induced labour
  • Parturient in latency phase
  • Term ≥ 37SA
  • END \> 3
  • Parturient requiring active pain management (medicinal or non-medicinal)
  • Low-risk pregnancy
  • Exclusion Criteria:
  • Parturient under legal protection
  • Parturient with a hearing impairment
  • Parturient with visual impairment
  • Parturient with epilepsy
  • Parturient with psychiatric problems
  • Pathological pregnancy
  • Parturient with chronic pain
  • Parturient with addiction-related disorders
  • Parturient allergic to paracetamol
  • Parturient allergic to phloroglucinol
  • Parturient allergic to codeine
  • Parturient allergic to nalbuphine
  • Parturient allergic to orozamudol

About Centre Hospitalier Universitaire, Amiens

The Centre Hospitalier Universitaire (CHU) Amiens is a leading academic medical center in France dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on multidisciplinary collaboration, CHU Amiens integrates patient care, education, and research to enhance treatment outcomes and improve patient quality of life. The institution is committed to ethical standards and regulatory compliance in its clinical research endeavors, aiming to contribute significantly to the medical community and the development of new therapeutic approaches. By fostering partnerships with various stakeholders, CHU Amiens strives to translate scientific discoveries into practical applications that benefit patients and healthcare systems alike.

Locations

Amiens, Picardie, France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported